重症儿童与新生儿万古霉素常见剂量不足
本研究回顾性分析了10个月内某三级儿科与新生儿重症监护病房中115例患儿接受的126个静脉万古霉素疗程。仅30%的疗程在初始稳态谷浓度时达到10-20 mg/L的目标浓度,且浓度不达标时仅56%调整了剂量。万古霉素相关肾毒性发生率为8%,建议新生儿(纠正胎龄<35周)至少30 mg/kg/日、年长儿至少50 mg/kg/日,并优化TDM流程。
要点
- 仅30%的初始稳态谷浓度达标(10-20 mg/L),剂量不足常见。
- 浓度不达标时仅56%的疗程进行了剂量调整。
- 纠正胎龄<35周新生儿需≥30 mg/kg/日,年长儿需≥50 mg/kg/日。
核心结论
- 重症儿童和新生儿万古霉素常见剂量不足,需个体化给药并优化TDM。
研究设计与样本
- 回顾性研究,纳入某三级儿科与新生儿重症监护病房10个月内接受静脉万古霉素且至少有一次稳态TDM血样的115例患儿,共126个疗程。
主要发现
- 126个疗程中仅38个(30%)初始稳态谷浓度达到10-20 mg/L目标范围。
- 88个初始谷浓度不在目标范围的疗程中,仅49个(56%)进行了剂量调整。
- 万古霉素相关肾毒性发生于10/126(8%)个疗程,未发生红人综合征。
关键数值与推荐
- 目标谷浓度为10-20 mg/L。
- 纠正胎龄<35周的新生儿最低剂量需≥30 mg/kg/日以达到目标浓度。
- 年长儿最低剂量需≥50 mg/kg/日以达到目标浓度。
临床怎么用
- 在缺乏贝叶斯模型指导给药时,肾功能正常的新生儿(纠正胎龄<35周)可考虑经验性万古霉素至少30 mg/kg/日。
- 肾功能正常的年长儿可考虑经验性万古霉素至少50 mg/kg/日。
- 应通过制定方案(最好嵌入电子病历)来优化TDM实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Vancomycin is frequently used in critically ill children in whom the drug pharmacokinetics are significantly altered as a result of changes in renal clearance and volume of distribution. Therapeutic drug monitoring (TDM) is recommended to achieve vancomycin trough concentrations between 10 and 20 mg/L. In this study we reviewed vancomycin dosing, TDM and treatment outcomes in paediatric and neonatal intensive care unit patients. METHODS: We reviewed the medical records of all patients receiving intravenous vancomycin in a tertiary paediatric and neonatal intensive care unit over a 10-month period. Demographic, vancomycin dosing, TDM and drug-related adverse effects data were collected. RESULTS: In total, 115 children received 126 courses of vancomycin and had at least 1 TDM blood sample taken at steady state. In only 38/126 (30%) courses was the target concentration (10-20 mg/L) achieved at the initial steady state trough sample. Of the 88 courses that had initial trough concentrations outside the target range, the dose was adjusted in only 49 (56%). Overall, minimum doses of 30 mg/kg/day in neonates with a corrected gestational age of <35 weeks, and 50 mg/kg/day in older children, were required to achieve target vancomycin concentrations. Vancomycin-attributable nephrotoxicity occurred in 10/126 (8%) courses and there were no episodes of red man syndrome. CONCLUSION: In critically ill children, individualised dosing is needed. In the absence of Bayesian model-based dosing, in children with normal renal function, empiric vancomycin doses of at least 30 mg/kg/day in neonates of <35 weeks corrected gestational age, and 50 mg/kg/day in older children, should be considered. Optimisation of TDM practices through the development of protocols, ideally built into electronic medical records, should be considered.
引用
- Sosnin N, Curtis N, Cranswick N, et al. Vancomycin is commonly under-dosed in critically ill children and neonates. Br J Clin Pharmacol. 2019. PMID: 31378957. doi:10.1111/bcp.14084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。